Aqueous extract of

Mahdi Abdollahi-Karizno, Babak Roshanravan, Mahmoud Zardast, Mohsen Naseri

Open access · greenAbstract read

In one paragraph

Article in Journal of diabetes and metabolic disorders, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.2field-weighted citation impact, top 33% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mahdi Abdollahi-KariznoMedical Student, Student Research Committee, Birjand University of Medical Sciences, Birjand, IR Iran.

Babak RoshanravanMedical Student, Student Research Committee, Birjand University of Medical Sciences, Birjand, IR Iran.

Mahmoud ZardastAtherosclerosis and Coronary Artery Research Centre, Department of Pathology, Birjand University of Medical Sciences, Birjand, Iran.

Mohsen NaseriCellular and Molecular Research Center, Genomic Research Group, Birjand University of Medical Sciences, Ghafari Street, Birjand, Southern Khorasan Iran.ORCID 0000-0003-3100-6344

Birjand University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Prostatic complications are common among diabetic patients. Previous research demonstrates that Methods: Diabetes was induced in male Wistar rats by intraperitoneal injection of streptozotocin (50 mg/kg). a total of 40 Rats were randomly divided into the following groups: Control, Control + TP100 (TP100), Diabetic, Diabetic + TP100 (DTP100) and Diabetic + TP200 (DTP200). The intervention was done orally once per day for 56 days (8 weeks). An oral glucose tolerance test was conducted, glucose and insulin levels were assessed. Microscopic features of the ventral prostatic lobe were evaluated pathologically. Results: Conclusion: It could be deduced that Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-022-00979-4.

Indexed as

Diabetic ratPlasma insulin levelProstate histopathologyTeucrium polium

Identifiers

PMID36404824

DOI10.1007/s40200-022-00979-4

PMCPMC9672261

OpenAlexW4285728685

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.